Tjalke A. Westra - Publications, H-index & Citations

Tjalke A. Westra

Moderna Inc

13H指数

40论文数

525被引数

收录论文 19

发表时间

Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands 荷兰常规婴儿脑膜炎B疫苗接种的成本效益

Infectious Diseases and Therapy

IF5.3

2026-06-26

OAAI

Joost J. M. Simons; Florian Zeevat; Tjalke A. Westra; Jan C. Wilschut; Nina M. van Sorge; Cornelis Boersma; Maarten J. Postma

A qualitative study on vaccination program accessibility for the elderly and medical risk groups in the south of the Netherlands 一项关于荷兰南部老年人及医疗风险群体疫苗接种项目可及性的定性研究

vaccine

IF2.2

2025-08-27

OAAI

May Nhu Vu; Tjalke Arend Westra; Mickael Hiligsmann

Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands

ADVANCES IN THERAPY

IF4

2025-02-10

OAAI

Zeevat, Florian; van der Pol, Simon; Westra, Tjalke; Beck, Ekkehard; Postma, Maarten J.; Boersma, Cornelis

The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective

EXPERT REVIEW OF VACCINES

IF4.8

2014-12-06

OAAI

Setiawan, Didik; Luttjeboer, Jos; Westra, Tjalke Arend; Wilschut, Jan C.; Suwantika, Auliya A.; Daemen, Toos; Atthobari, Jarir; Wilffert, Bob; Postma, Maarten J.

COST-EFFECTIVENESS OF HUMAN PAPILOMAVIRUS VACCINATION PROGRAMMES PARALLEL TO CURRENT ROUTINE VACCINATION OF YOUNG TEENAGE GIRLS

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Westra, T. A.; Postma, M. J.

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands

BMC PUBLIC HEALTH

IF3.6

2014-03-28

OAAI

Mollers, Madelief; Lubbers, Karin; Spoelstra, Symen K.; Weijmar-Schultz, Willibrord C. M.; Daemen, Toos; Westra, Tjalke A.; van der Sande, Marianne A. B.; Nijman, Hans W.; de Melker, Hester E.; Tami, Adriana

Accumulating evidence for the case of differential discounting

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2014-01-10

OAAI

Postma, Maarten J.; Parouty, Mehraj; Westra, Tjalke A.

Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around ...

EXPERT REVIEW OF VACCINES

IF4.8

2014-01-09

PREAI

Rozenbaum, Mark H.; De Cao, Elisabetta; Westra, Tjalke A.; Postma, Maarten J.

Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples

EXPERT REVIEW OF VACCINES

IF4.8

2014-01-09

PREAI

Postma, Maarten J.; Westra, Tjalke A.; Quilici, Sibilia; Largeron, Nathalie

Untitled

CLINICAL THERAPEUTICS

IF3.6

2013-07-01

PREAI

Westra, Tjalke A.; Fortanier, Sander C.; Delgleize, Emmanuelle; Mrkvan, Tomas

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands 在荷兰进行人乳头瘤病毒疫苗接种的成本效益分析中，包括增强对宫颈癌的交叉保护和生殖器疣的预防的益处

BMC INFECTIOUS DISEASES

IF3

2013-02-07

OAAI

Westra, Tjalke A.; Stirbu-Wagner, Irina; Dorsman, Sara; Tutuhatunewa, Eric D.; de Vrij, Edwin L.; Nijman, Hans W.; Daemen, Toos; Wilschut, Jan C.; Postma, Maarten J.

ANALYSIS OF THE IMPACT OF PROPHYLACTIC VACCINATION AGAINST HUMAN PAPILLOMAVIRUS INFECTION USING A DYNAMIC-MODELLING APPROACH

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Westra, T.; Nijman, H.; Wilschut, J.; Daemen, T.; Postma, M.

DIFFERENTIAL TIME PREFERENCE FOR MONEY, LIFE YEARS AND QUALITY OF LIFE: AN EMPIRICAL PILOT STUDY

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Parouty, M.; Krooshof, D.; Westra, T.; Pechlivanoglou, P.; Postma, M.

METHODS FOR DISCOUNTING IN ECONOMIC EVALUATION; AN EMPIRICAL COMPARISON OF PREFERENCES IN MONEY AND QUALITY OF LIFE

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Parouty, M.; Krooshof, D.; Westra, T.; Postma, M.

On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches

VALUE IN HEALTH

IF6

2012-05-01

OAAI

Westra, Tjalke A.; Parouty, Mehraj; Brouwer, Werner B.; Beutels, Philippe H.; Rogoza, Raina M.; Rozenbaum, Mark H.; Daemen, Toos; Wilschut, Jan C.; Boersma, Cornelis; Postma, Maarten J.

Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis

VALUE IN HEALTH

IF6

2011-12-01

OAAI

Westra, Tjalke A.; Parouty, Mehraj B. Y.; Wilschut, Jan C.; Boersma, Cornelis; Postma, Maarten J.

Until Which Age Should Women Be Vaccinated Against HPV Infection? Recommendation Based on Cost-effectiveness Analyses

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2011-08-01

PREAI

Westra, Tjalke A.; Rozenbaum, Mark H.; Rogoza, Raina M.; Nijman, Hans W.; Daemen, Toos; Postma, Maarten J.; Wilschut, Jan C.

Cost-Effectiveness Analysis of Various Pertussis Vaccination Strategies Primarily Aimed at Protecting Infants in the Netherlands

CLINICAL THERAPEUTICS

IF3.6

2010-08-01

OAAI

Westra, Tjalke A.; de Vries, Robin; Tamminga, Johannes J.; Sauboin, Christophe J.; Postma, Maarten J.

COST-EFFECTIVENESS OF A PROPHYLACTIC HUMAN PAPILLOMA VIRUS 16/18 VACCINE FOR 12-YEAR-OLD DUTCH GIRLS

VALUE IN HEALTH

IF6

2008-11-01

OAAI

Westra, T. A.; Rogoza, R.; Ferko, N.; Tamminga, J. J.; Drummond, M. F.; Wilschut, J. C.; Postma, M. J.

研究方向